Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3

Biochemical Pharmacology

Volumn 65, Issue 1, 2003, Pages 75-82

  Kim, Seung Whan ^a,c   Kwon, Hyog young ^a   Chi, Dong Whan ^a   Shim, Jai Heon ^a   Park, Jong Dae ^b   Lee, You Hui ^b   Pyo, Suhkneung ^a   Rhee, Dong Kwon ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

20(S) Ginsenoside Rg3; Multidrug resistance (MDR); P glycoprotein (Pgp); Panax ginseng

Indexed keywords

AZIDOPINE; COLCHICINE; DOXORUBICIN; ETOPOSIDE; GINSENOSIDE; GINSENOSIDE RG 3; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TRANSPORT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIFESPAN; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

AFFINITY LABELS; ANIMALS; AZIDES; BIOLOGICAL TRANSPORT; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE; FLUORESCENT DYES; GINSENOSIDES; HUMANS; KB CELLS; LEUKEMIA P388; MICE; P-GLYCOPROTEIN; RHODAMINE 123; TRITIUM; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0037212768     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01446-6     Document Type: Article

References (43)

1. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
2. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-171.
3. Gros P., Ben Neriah Y., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
4. Herzog C.E., Tsokos M., Bates S.E., Fojo A.T. Increased mdr1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J. Biol. Chem. 268:1993;2946-2952.
5. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40(Suppl.):1997;S3-S8.
6. Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutherford A.V., Willingham M.A. Retrovirus carrying an mdr1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4486-4490.
7. Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:1990;155-199.
8. Dale I.L., Tuffley W., Callaghan R., Holmes J.A., Martin K., Luscombe M., Mistry P., Ryder H., Stewart A.J., Charlton P., Twentyman P.R., Bevan P. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. Br. J. Cancer. 78:1998;885-892.
9. Dantzig A.H., Shepard R.L., Cao J., Law K.L., Ehlhardt W.J., Baughman T.M., Bumol T.F., Starling J.J. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzo suberane modulator LY335979. Cancer Res. 56:1996;4171-4179.
10. Bichat F., Solis-Recendez G., Poullain M.G., Poupon M.F., Khayat D., Bastian G. S9788 modulation of P-glycoprotein- and multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells. Biochem. Pharmacol. 56:1998;497-502.
11. Newman M.J., Rodarte J.C., Benbatoul K.D., Romano S.J., Zhang C., Krane S., Moran E.J., Uyeda R.T., Dixon R., Guns E.S., Mayer L.D. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res. 60:2000;2964-2972.
12. Sparreboom A., Planting A.S., Jewell R.C., van der Burg M.E., van der Gaast A., de Bruijn P., Loos W.J., Nooter K., Chandler L.H., Paul E.M., Wissel P.S., Verweij J. Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein. Anticancer Drugs. 10:1999;719-728.
13. Atadja P., Watanabe T., Xu H., Cohen D. PSC-833, a frontier in modulation of P-glycoprotein-mediated multidrug resistance. Cancer Metastasis Rev. 17:1998;163-168.
14. Vanhoefer U., Cao S., Minderman H., Toth K., Scheper R.J., Slovak M.L., Rustum Y.M. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. Clin. Cancer Res. 2:1996;369-377.
15. Coon J.T., Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 25:2002;323-344.
16. Zhu M., Chan K.W., Ng L.S., Chang Q., Chang S., Li R.C. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol. 51:1999;175-180.
17. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58:1999;1685-1693.
18. Gillis C.N. Panax ginseng pharmacology: a nitric oxide link? Biochem. Pharmacol. 54:1997;1-8.
19. Kitagawa I., Yoshikawa M., Yoshihara M., Hayashi T., Taniyama T. Chemical studies of crude drugs (1). Constituents of Ginseng radix rubra. Yakugaku Zasshi. 103:1983;612-622.
20. WAF/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem. 275:2000;30256-30263.
21. Molnar J., Szabo D., Pusztai R., Mucsi I., Berek L., Ocsovszki I., Kawata E., Shoyama Y. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivatives. Anticancer Res. 20:2000;861-867.
22. Park J.D., Kim D.S., Kwon H.Y., Son S.K., Lee Y.H., Baek N.I., Kim S.I., Rhee D.K. Effects of ginseng saponin on modulation of multidrug resistance. Arch. Pharm. Res. 19:1996;213-218.
23. Chen H.X., Bamberger U., Hechel A., Guo X., Cheng Y.C. BIBW22, a dipyridamole analog, acts as a bifunctional modulator on tumor cells by influencing both P-glycogen and nucleoside transport. Cancer Res. 53:1993;1974-1977.
24. Ludescher C., Gattringer C., Drach J., Hofmann J., Grunicke H. Rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine 123. Blood. 78:1991;1385-1387.
25. Safa A.R. Photo-affinity labeling of the multidrug-resistance-related P-glycoprotein with photo-active analogs of verapamil. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7187-7191.
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989.
29. Bichat F., Mouawad R., Solis-Recendez G., Khayat D., Bastian G. Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line. Anticancer Res. 17:1997;3393-3401.
30. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1990;1107-1112.
31. Yoshimura A., Shudo N., Ikeda S.I., Ichikawa M., Sumizawa T., Akiyama S.I. Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Lett. 50:1990;45-51.
32. Odani T., Tanizawa H., Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem. Pharm. Bull. 31:1983;292-298.
33. Tanaka O., Nagai M., Shibata S. Chemical studies on the oriental plant drugs. XVI. The stereochemistry of protopanaxadiol, a genuine sapogenin of ginseng. Chem. Pharm. Bull. (Tokyo). 14:1966;1150-1156.
34. Whiting K.P., Restall C.J., Brain P.F. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci. 67:2000;743-757.
35. Yang C.P., DePinho S.G., Greenberger L.M., Arceci R.J., Horwitz S.B. Progesterone interacts with P-glycoprotein in multidrug-resistant clees and the endometrium of gravid uterus. J. Biol. Chem. 265:1989;782-788.
36. Jancis E.M., Chen H.X., Carbone R., Hochberg R.B., Dannies P.S. Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone. Biochem. Pharmacol. 46:1993;1613-1619.
37. Tachikawa E., Kudo K., Nunokawa M., Kashimoto T., Takahashi E., Kitagawa S. Characterization of ginseng saponin ginsenoside-Rg(3) inhibition of catecholamine secretion in bovine adrenal chromaffin cells. Biochem. Pharmacol. 62:2001;943-951.
38. Liu W.K., Xu S.X., Che C.T. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67:2000;1297-1306.
39. Iishi H., Tatsuta M., Baba M., Uehara H., Nakaizumi A., Shinkai K., Akedo H., Funai H., Ishiguro S., Kitagawa I. Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin. Exp. Metastasis. 15:1997;603-611.
40. Tachikawa E., Kudo K., Harada K., Kashimoto T., Miyate Y., Kakizaki A., Takahashi E. Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369:1999;23-32.
41. 2+ channel currents in rat sensory neurons. Eur. J. Pharmacol. 436:2002;151-158.
42. Kim Y.C., Kim S.R., Markelonis G.J., Oh T.H. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res. 53:1998;426-432.
43. + channels. Eur. J. Pharmacol. 367:1999;51-57.